FTO and prostate cancer: In addition, the expression levels of METTL3 (Li et al., 2020), FTO (Zhu, Li & Xu, 2021), YTHDF1-2, YTHDC2 (Wu et al., 2021a) were positively correlated with the Gleason score of prostate cancer.